Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Rémy Choquet"'
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background Patient information in rare disease registries is generally collected from numerous data sources, necessitating the data to be federated. In addition, data for research purposes must be de-identified. Transforming nominative data
Externí odkaz:
https://doaj.org/article/d31b0b9799054caf9df93615c5f7df83
Autor:
Geneviève Baujat, Rémy Choquet, Stéphane Bouée, Viviane Jeanbat, Laurène Courouve, Amélie Ruel, Caroline Michot, Kim-Hanh Le Quan Sang, David Lapidus, Claude Messiaen, Paul Landais, Valérie Cormier-Daire
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-9 (2017)
Abstract Background Fibrodysplasia ossificans progressiva (FOP) is a rare, severely disabling, and life-shortening genetic disorder that causes the formation of heterotopic bone within soft connective tissue. Previous studies found that the FOP preva
Externí odkaz:
https://doaj.org/article/fa5789982ed84d569627d031e2a90e77
Autor:
Lisa Friedlander, Rémy Choquet, Eva Galliani, Myriam de Chalendar, Claude Messiaen, Amélie Ruel, Marie-Paule Vazquez, Ariane Berdal, Corinne Alberti, Muriel De La Dure Molla
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-13 (2017)
Abstract Background In the last ten years, national rare disease networks have been established in France, including national centres of expertise and regional ones, with storage of patient data in a bioinformatics tool. The aim was to contribute to
Externí odkaz:
https://doaj.org/article/799b71fc01f84966a833731c3a1ef7ee
Autor:
Katia Thokagevistk, Céline Coppo, Laetitia Rey, Amanda Carelli, Veronica Díez, Sarah Vaselenak, Liana Oliveira, Ajay Patel, Emilia Sicari, Teresa Ramos, Susanne Schach, Erika Schirghuber, Alex Simpson, Remy Choquet, Katell Le Lay
Publikováno v:
Journal of Market Access & Health Policy, Vol 12, Iss 2, Pp 105-117 (2024)
Background: Real-world evidence (RWE) can reinforce clinical trial evidence in health technology assessment (HTA). Objectives: Review HTA bodies’ (HTAbs) requirements for RWE, real uses, and acceptance across seven countries (Brazil, Canada, France
Externí odkaz:
https://doaj.org/article/402fac064ee64a2797cde8a8b2c31ab4
Autor:
C. Chapolard, L. Larmet, A. Becker, I. Madelaine, Rémy Choquet, M. Danet, Stéphane Morel, S. Parlier, N. Hall, E. Dalle, M Saouzanet, F. Clement, Y Saïdi, E. Rosenthal, M. Meunier, L. Zarka, C. Etienne, S. Rouby, Péchenot, J. Delgado, N. Dumon, S. Cousseau, M. Cavellec, M Suzan, Catherine Capitant, D. Ponscarme, B. Boissavy, S. Pailhes, Claire Pintado, Chloé Le Roy, C. Bernaud, J. Koffi, A. Djessima, P M Roger, A. Adda, Cécile Bébéar, B. Bonnet, F. Bonnet, H. Hue, Emmanuelle Netzer, Baptiste Demoulin, N Leturque, C. Gatey, Nadège Bourgeois-Nicolaos, F Euphrasie, Béatrice Berçot, C. Adouard-groslafeige, P. Penot, François Raffi, M. Godinot, R. Biekre, C. Monfort, Naoufel Mzoughi, F. Jeanblanc, A Cheret, Armelle Pasquet, Laurence Meyer, B Guillon, T. Huleux, Constance Delaugerre, J. Lambec, O. Leclanche, S. Bagge, R. Veron, Gilles Pialoux, G. Conort, B. Loze, S. le Nagat, F. Tolonin, Christian Chidiac, Sabine Pereyre, Nicolas Lorente, Berrebi, N. Mezreb, T. Cepitelli, A. Decouty, H. Melliez, S. Vandamme, A. Pansu, Michel Besnier, M. Colas, H. Bazus, Isabelle Charreau, W. Rozenbaum, X. Teruin, S. Huon, K. Moudachirou, Eric Senneville, J. Foucoin, L. Gilly, Foubert, P. Cornavin, Clotilde Rousseau, F. Lorho, J. Berdougo, S Fouéré, S. Breaud, C. Brochier, N. Mahjoub, G Cattin, J Binesse, Jean-Michel Molina
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 73(7)
Background Mycoplasma genitalium (MG) is an emerging pathogen among men who have sex with men (MSM) with raising rates of antibiotic resistance. This study assessed the prevalence and incidence of MG infection in MSM enrolled in the open-label phase
Autor:
Simon Stones, Christian Pristipino, Rémy Choquet, Francis Berenbaum, Axel Finckh, Laure Gossec, Hervé Servy, Timothy R D J Radstake, Gerd R Burmester, Tanja Stamm, Joanna Kedra, Aridaman Pandit, David Gomez-Cabrero, Xenofon Baraliakos
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, pp.annrheumdis-2019-215694. ⟨10.1136/annrheumdis-2019-215694⟩
Annals of the Rheumatic Diseases, 79(1), 69. BMJ Publishing Group
Annals of the Rheumatic Diseases, Vol. 79, No 1 (2020) pp. 69-76
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, pp.annrheumdis-2019-215694. ⟨10.1136/annrheumdis-2019-215694⟩
Annals of the Rheumatic Diseases, 79(1), 69. BMJ Publishing Group
Annals of the Rheumatic Diseases, Vol. 79, No 1 (2020) pp. 69-76
BackgroundTremendous opportunities for health research have been unlocked by the recent expansion of big data and artificial intelligence. However, this is an emergent area where recommendations for optimal use and implementation are needed. The obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c374e6f1562cd0966a86eafe6a92c65
https://hal.sorbonne-universite.fr/hal-02409516/document
https://hal.sorbonne-universite.fr/hal-02409516/document
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, BioMed Central, 2018, 13 (1), ⟨10.1186/s13023-018-0948-6⟩
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-9 (2018)
Orphanet Journal of Rare Diseases, BioMed Central, 2018, 13 (1), ⟨10.1186/s13023-018-0948-6⟩
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-9 (2018)
International audience; Background : Patient information in rare disease registries is generally collected from numerous data sources, necessitating the data to be federated. In addition, data for research purposes must be de-identified. Transforming
Autor:
Paul Landais, Claude Messiaen, Viviane Jeanbat, Valérie Cormier-Daire, David Lapidus, Laurène Courouve, Kim-Hanh Le Quan Sang, Amélie Ruel, Caroline Michot, Geneviève Baujat, Rémy Choquet, Stéphane Bouée
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, BioMed Central, 2016, 12 (1), pp.123. ⟨10.1186/s13023-017-0674-5⟩
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-9 (2017)
Orphanet Journal of Rare Diseases, BioMed Central, 2016, 12 (1), pp.123. 〈10.1186/s13023-017-0674-5〉
Orphanet Journal of Rare Diseases, 2016, 12 (1), pp.123. ⟨10.1186/s13023-017-0674-5⟩
Orphanet Journal of Rare Diseases, BioMed Central, 2016, 12 (1), pp.123. ⟨10.1186/s13023-017-0674-5⟩
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-9 (2017)
Orphanet Journal of Rare Diseases, BioMed Central, 2016, 12 (1), pp.123. 〈10.1186/s13023-017-0674-5〉
Orphanet Journal of Rare Diseases, 2016, 12 (1), pp.123. ⟨10.1186/s13023-017-0674-5⟩
International audience; AbstractBackgroundFibrodysplasia ossificans progressiva (FOP) is a rare, severely disabling, and life-shortening genetic disorder that causes the formation of heterotopic bone within soft connective tissue. Previous studies fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::176cef9ad018fe8e65e434d817f2e73e
https://www.hal.inserm.fr/inserm-01552312/file/13023_2017_Article_674.pdf
https://www.hal.inserm.fr/inserm-01552312/file/13023_2017_Article_674.pdf
Autor:
Simon Stones, Hervé Servy, Axel Finckh, Tanja Stamm, Aridaman Pandit, Francis Berenbaum, Laure Gossec, Xenofon Baraliakos, Christian Pristipino, Joanna Kedra, Bruno Fautrel, Gerd R Burmester, David Gomez-Cabrero, Rémy Choquet, Timothy R D J Radstake
Publikováno v:
RMD Open
Open
Open, J. Wiltenburg, 2019, 5 (2), pp.e001004. ⟨10.1136/rmdopen-2019-001004⟩
Open
Open, J. Wiltenburg, 2019, 5 (2), pp.e001004. ⟨10.1136/rmdopen-2019-001004⟩
ObjectiveTo assess the current use of big data and artificial intelligence (AI) in the field of rheumatic and musculoskeletal diseases (RMDs).MethodsA systematic literature review was performed in PubMed MEDLINE in November 2018, with key words refer
Publikováno v:
Ingénierie des systèmes d'information. 18:59-82
This article deals with the problematic of biomedical information sharing in the study of antibioresistance growth in Europe. Our general working hypothesis is: how can we share biomedical information in Europe in a non ambiguous way, in a fast way,